[Control of hypertension in the Czech part of the Pardubice-Augsburg Study].

Vnitr Lek

Kardiologické oddĕlení Nemocnice, Pardubice.

Published: November 1998

Objective of the work is to evaluate the prevalence of arterial hypertension, awareness of it, its treatment and control in the Czech part of the Pardubice-Augsburg Study. A random sample of 191 men aged 45-64 years was invited for examination. Arterial hypertension according to the present definition of WHO/International Society of Hypertension (blood pressure > or = 140/90 mm Hg = 18.8/12kPa) was recorded in 113 subjects, its prevalence being 59% .55% hypertensive patients were aware of their diagnosis. 40% of the hypertensive patients were on pharmacological treatment. Hypertension control was achieved in 9% of the treated and in 4% of all hypertensive subjects. Hypertension Control in the investigated representative population sample is inadequate. The greatest problem the inadequate reduction of blood pressure to target values. Comparison of hypertension control using older (BP > or = 160/95 mm Hg = 21.3/12.6 kPa) and present (BP > or = 140/90 mm Hg = 18.6/12 kPa) definitions of arterial hypertension suggests that the great majority of unsuccessfully treated hypertensive subjects has borderline blood pressure values.

Download full-text PDF

Source

Publication Analysis

Top Keywords

arterial hypertension
12
blood pressure
12
hypertension control
12
czech pardubice-augsburg
8
hypertensive patients
8
treated hypertensive
8
hypertensive subjects
8
hypertension
7
[control hypertension
4
hypertension czech
4

Similar Publications

Severe Maternal Morbidity Associated With Chronic Hypertension, Preeclampsia, and Gestational Hypertension.

JAMA Netw Open

January 2025

Magee-Womens Research Institute, Department of Obstetrics, Gynecology and Reproductive Sciences, Epidemiology and Clinical and Translational Research, University of Pittsburgh, Pittsburgh, Pennsylvania.

Importance: Chronic hypertension and preeclampsia are leading risk enhancers for maternal-neonatal morbidity and mortality. Severe maternal morbidity (SMM) indicators include heart, kidney, and liver disease, but studies have not excluded patients with preexisting diseases that define SMM. Thus, SMM risks for uncomplicated chronic hypertension specific to preeclampsia remain unclear.

View Article and Find Full Text PDF

Fostamatinib had superior efficacy to a placebo and acceptable safety profiles for at least 1 year in a phase 3 study of Japanese patients with primary immune thrombocytopenia. Here, we report the 3-year safety and efficacy of fostamatinib in that study. Data from 33 patients who received at least one dose of fostamatinib were analyzed.

View Article and Find Full Text PDF

Background: Primary aldosteronism (PA) is the leading surgically treatable cause of hypertension, with adrenalectomy as the definitive treatment for unilateral PA (UPA). However, some patients have persistent hypertension after surgery. This study aims to identify preoperative factors affecting surgical outcomes and develop a predictive model for postoperative hypertension resolution.

View Article and Find Full Text PDF

Retraction Note: Letter to Editor, "Giant unruptured middle cerebral artery aneurysm revealed by intracranial hypertension: is a systematic decompressive hemicraniotomy mandatory?

Neurosurg Rev

January 2025

Lab in Biotechnology and Biosignal Transduction, Department of Orthodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai-77, Tamil Nadu, India.

View Article and Find Full Text PDF

Introduction: Pelvic ring fractures are known to be associated with complications associated with adjacent organ injuries, such as the urogenital tract (e.g. erectile dysfunction (ED), which are sometimes diagnosed in a delayed fashion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!